Serina Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Serina Therapeutics, Inc. (SER) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $24.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-05-14
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $24.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $35.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $24.00K.
- 2025-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $29.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-03-31 | $24.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $35.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $24.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $29.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $21.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $43.00K 10-K · filed 2025-03-24 |
| 2024-09-30 | $50.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $54.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $63.00K 10-Q · filed 2024-05-14 |
| 2020-09-30 | $1.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $4.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $8.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $12.00K 10-K/A · filed 2020-03-31 |
| 2019-09-30 | $19.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $27.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |